1-9 of 9
Lindsay L. Peterson
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 3409: AGEing and lifestyle after a cancer diagnosis: A balanced equilibrium for survivorship

Free
David P. Turner, Bradley A. Krisanits, Marvella E. Ford, Lindsay L. Peterson, Susan E. Steck, Paula D. Bos, Victoria J. Findlay
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 3409.
https://doi.org/10.1158/1538-7445.AM2024-3409
Published: 22 March 2024
View articletitled, Abstract 3409: AGEing and lifestyle after a cancer diagnosis: A balanced equilibrium for survivorship
Journal Articles

Abstract OT3-11-01: TK IMPACT: Treatment Monitoring of Hormone Receptor Positive (HR+), HER2 Negative (HER2-) Metastatic Breast Cancer (MBC) Patients Receiving CDK 4/6 Inhibitors (CDK4/6i) with DiviTum® Thymidine Kinase 1 Activity

Free
Nusayba A. Bagegni, Isabella Grigsby, Leslie Nehring, Jingqin Luo, Jennifer Powers Carson, David W. Gibson, Meghan Horvath, Katherine K. Clifton, Foluso O. Ademuyiwa, Rama Suresh, Ashley Frith, Andrew A. Davis, Lindsay L. Peterson, Ron Bose, Amy Williams, Mattias Bergqvist, Cynthia Ma
Journal: Cancer Research
Cancer Res (2023) 83 (5_Supplement): OT3-11-01.
https://doi.org/10.1158/1538-7445.SABCS22-OT3-11-01
Published: 01 March 2023
View articletitled, Abstract OT3-11-01: TK IMPACT: Treatment Monitoring of Hormone Receptor Positive (HR+), HER2 Negative (HER2-) Metastatic Breast Cancer (MBC) Patients Receiving CDK 4/6 Inhibitors (CDK4/6i) with DiviTum® Thymidine Kinase 1 Activity
Journal Articles

Abstract P3-06-06: Real-world analysis of adverse events of patients with triple negative breast cancer receiving therapy per KEYNOTE-522

Free
Mara Hofherr, Jennifer Hedgecorth, Foluso O. Ademuyiwa, Lindsay L. Peterson, Nusayba A. Bagegni, Rama Suresh, Ashley Frith, Ron Bose, Katherine Weilbaecher, Cynthia Ma, Andrew A. Davis, Katherine K. Clifton
Journal: Cancer Research
Cancer Res (2023) 83 (5_Supplement): P3-06-06.
https://doi.org/10.1158/1538-7445.SABCS22-P3-06-06
Published: 01 March 2023
View articletitled, Abstract P3-06-06: Real-world analysis of adverse events of patients with triple negative breast cancer receiving therapy per KEYNOTE-522
Journal Articles

Abstract PD13-09: PD13-09 Clinical outcomes of patients with HR+ HER2- advanced breast cancer with early progression on CDK4/6 inhibitors

Free
Katherine K. Clifton, Shana N. Thomas, Jingqin Luo, Jing Xi, Nusayba A. Bagegni, Foluso O. Ademuyiwa, Rama Suresh, Ashley Frith, Andrew A. Davis, Ron Bose, Katherine Weilbaecher, Whitney L. Hensing, Timothy Pluard, Massimo Cristofanilli, Hyo S. Han, Adam M. Brufsky, Kevin Kalinsky, Shom Goel, Seth A. Wander, Lindsay L. Peterson, Cynthia Ma
Journal: Cancer Research
Cancer Res (2023) 83 (5_Supplement): PD13-09.
https://doi.org/10.1158/1538-7445.SABCS22-PD13-09
Published: 01 March 2023
View articletitled, Abstract PD13-09: PD13-09 Clinical outcomes of patients with HR+ HER2- advanced breast cancer with early progression on CDK4/6 inhibitors
Journal Articles

Abstract PD12-09: PD12-09 Serum Advanced Glycation End-Products are Associated with Breast Cancer Prognosis

Free
Lindsay L. Peterson, Yu Tao, Jingqin Luo, Graham A. Colditz, Yikyung Park, Jennifer A. Ligibel, David Turner
Journal: Cancer Research
Cancer Res (2023) 83 (5_Supplement): PD12-09.
https://doi.org/10.1158/1538-7445.SABCS22-PD12-09
Published: 01 March 2023
View articletitled, Abstract PD12-09: PD12-09 Serum Advanced Glycation End-Products are Associated with Breast Cancer Prognosis
Journal Articles

Abstract P5-13-20: Identifying a metabolite signature that correlates with tumor proliferation in early-stage breast cancer patients treated with CDK4/6 inhibitors from matched plasma and serum samples

Free
Chen Dong, Shana Thomas, Chandrashekhar Honrao, Leonardo O. Rodrigues, Nathalie Tessier, Bo Zhang, Souzan Sanati, Kiran Vij, Brenda J. Ernst, Karen S. Anderson, Mateusz Opyrchal, Foluso Ademuyiwa, Lindsay L. Peterson, Matthew P. Goetz, Donald Northfelt, Elizabeth O'Day, Cynthia Ma
Journal: Cancer Research
Cancer Res (2022) 82 (4_Supplement): P5-13-20.
https://doi.org/10.1158/1538-7445.SABCS21-P5-13-20
Published: 15 February 2022
View articletitled, Abstract P5-13-20: Identifying a metabolite signature that correlates with tumor proliferation in early-stage breast cancer patients treated with CDK4/6 inhibitors from matched plasma and serum samples
Journal Articles

Abstract 619: Dietary advanced glycation end-products and postmenopausal breast cancer risk in the NIH AARP diet and health study

Free
Lindsay L. Peterson, Seho Park, Yikyung Park, Narges Anbardar, David Turner
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 619.
https://doi.org/10.1158/1538-7445.AM2019-619
Published: 01 July 2019
View articletitled, Abstract 619: Dietary advanced glycation end-products and postmenopausal breast cancer risk in the NIH AARP diet and health study
Journal Articles

Evidence for an Overweight Paradox in Cancer: Insights from Body Composition—Reply to Counterpoint

Free
Yikyung Park, Lindsay L. Peterson, Graham A. Colditz
Journal: Cancer Research
Cancer Res (2018) 78 (8): 1913.
https://doi.org/10.1158/0008-5472.CAN-17-3701
Published: 12 April 2018
View articletitled, Evidence for an Overweight Paradox in Cancer: Insights from Body Composition—Reply to Counterpoint
Open the PDF for Evidence for an Overweight Paradox in Cancer: Insights from Body Composition—Reply to Counterpoint in another window
Journal Articles

The Plausibility of Obesity Paradox in Cancer—Point

Free
Yikyung Park, Lindsay L. Peterson, Graham A. Colditz
Journal: Cancer Research
Cancer Res (2018) 78 (8): 1898–1903.
https://doi.org/10.1158/0008-5472.CAN-17-3043
Published: 12 April 2018
View articletitled, The Plausibility of Obesity Paradox in Cancer—Point
Open the PDF for The Plausibility of Obesity Paradox in Cancer—Point in another window